The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model
BackgroundCefoperazone/sulbactam (CPZ/SAM) is an important treatment option for infections caused by multidrug-resistant gram-negative bacteria. However, it is associated with an increased risk of coagulation disorders (CD) and causes severe bleeding in some instances. Early identification of risk f...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1505653/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841561217930362880 |
|---|---|
| author | Changjing Xu Junlong Zhu Kun Tu Hui Tang Xinxin Zhou Qiuyu Li Kun Chen Xuping Yang Yilan Huang |
| author_facet | Changjing Xu Junlong Zhu Kun Tu Hui Tang Xinxin Zhou Qiuyu Li Kun Chen Xuping Yang Yilan Huang |
| author_sort | Changjing Xu |
| collection | DOAJ |
| description | BackgroundCefoperazone/sulbactam (CPZ/SAM) is an important treatment option for infections caused by multidrug-resistant gram-negative bacteria. However, it is associated with an increased risk of coagulation disorders (CD) and causes severe bleeding in some instances. Early identification of risk factors and prediction of CD related to CPZ/SAM are crucial for prevention and treatment. This study aimed to explore the risk factors and developed a nomogram model for predicting the risk of coagulopathy in patients undergoing CPZ/SAM treatment.MethodsA total of 1719 patients who underwent CPZ/SAM in the Affiliated Hospital of Southwest Medical University from August 2018 to August 2022, were recruited as the training cohort. For validation, 1,059 patients treated with CPZ/SAM from September 2022 to August 2024 were enrolled. Patients were divided into the CD and the N-CD groups. The occurrence of CD was designated as the dependent variable. The univariate and multivariate logistic regression analysis was performed to identify the risk factors of CD. A nomogram model was constructed from the multivariate logistic regression analysis and internally validated for model discrimination and calibration. The performance of the nomogram was estimated using the concordance index (C-index) and calibration curve.ResultsThe multivariate logistic regression analysis resulted in the following independent risk factors for CD: baseline INR level (OR: 5.768, 95% CI: 0.484∼11.372, p = 0.036), nutritional risk (OR:2.711, 95%CI: 1.495∼4.125, p < 0.001), comorbidity of digestive system (OR:1.287, 95%CI: 0.434∼2.215, p = 0.004), poor food intake (OR:1.261, 95%CI: 0.145∼2.473, p = 0.032), ALB level (OR: −0.132, 95%CI: −0.229∼-0.044, p = 0.005) and GFR< 30 mL/min (OR: 1.925, 95%CI: 0.704∼3.337, p = 0.004). The internal validation confirmed the model’s good performance (C-index, 0.905 [95% CI: 0.864∼0.945]). The calibration plots in the nomogram model were of high quality. Validation further confirmed the reliability of the nomogram, with a C-index of 0.886 (95% CI: 0.832–0.940).ConclusionThe nomogram model facilitated accurate prediction of CD in patients undergoing CPZ/SAM. And this could potentially contribute to reducing the incidence of CPZ/SAM-associated CD and consequently improving patients’ outcomes. |
| format | Article |
| id | doaj-art-cb1e83a3a7af471e9a19b6ce94fba34d |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-cb1e83a3a7af471e9a19b6ce94fba34d2025-01-03T04:13:53ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.15056531505653The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction modelChangjing Xu0Junlong Zhu1Kun Tu2Hui Tang3Xinxin Zhou4Qiuyu Li5Kun Chen6Xuping Yang7Yilan Huang8Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Vascular Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSchool of pharmacy, Southwest Medical University, Luzhou, ChinaDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSchool of pharmacy, Southwest Medical University, Luzhou, ChinaDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaBackgroundCefoperazone/sulbactam (CPZ/SAM) is an important treatment option for infections caused by multidrug-resistant gram-negative bacteria. However, it is associated with an increased risk of coagulation disorders (CD) and causes severe bleeding in some instances. Early identification of risk factors and prediction of CD related to CPZ/SAM are crucial for prevention and treatment. This study aimed to explore the risk factors and developed a nomogram model for predicting the risk of coagulopathy in patients undergoing CPZ/SAM treatment.MethodsA total of 1719 patients who underwent CPZ/SAM in the Affiliated Hospital of Southwest Medical University from August 2018 to August 2022, were recruited as the training cohort. For validation, 1,059 patients treated with CPZ/SAM from September 2022 to August 2024 were enrolled. Patients were divided into the CD and the N-CD groups. The occurrence of CD was designated as the dependent variable. The univariate and multivariate logistic regression analysis was performed to identify the risk factors of CD. A nomogram model was constructed from the multivariate logistic regression analysis and internally validated for model discrimination and calibration. The performance of the nomogram was estimated using the concordance index (C-index) and calibration curve.ResultsThe multivariate logistic regression analysis resulted in the following independent risk factors for CD: baseline INR level (OR: 5.768, 95% CI: 0.484∼11.372, p = 0.036), nutritional risk (OR:2.711, 95%CI: 1.495∼4.125, p < 0.001), comorbidity of digestive system (OR:1.287, 95%CI: 0.434∼2.215, p = 0.004), poor food intake (OR:1.261, 95%CI: 0.145∼2.473, p = 0.032), ALB level (OR: −0.132, 95%CI: −0.229∼-0.044, p = 0.005) and GFR< 30 mL/min (OR: 1.925, 95%CI: 0.704∼3.337, p = 0.004). The internal validation confirmed the model’s good performance (C-index, 0.905 [95% CI: 0.864∼0.945]). The calibration plots in the nomogram model were of high quality. Validation further confirmed the reliability of the nomogram, with a C-index of 0.886 (95% CI: 0.832–0.940).ConclusionThe nomogram model facilitated accurate prediction of CD in patients undergoing CPZ/SAM. And this could potentially contribute to reducing the incidence of CPZ/SAM-associated CD and consequently improving patients’ outcomes.https://www.frontiersin.org/articles/10.3389/fphar.2024.1505653/fullcefoperazone/sulbactamcoagulation disordersrisk factornomogrampredictive model |
| spellingShingle | Changjing Xu Junlong Zhu Kun Tu Hui Tang Xinxin Zhou Qiuyu Li Kun Chen Xuping Yang Yilan Huang The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model Frontiers in Pharmacology cefoperazone/sulbactam coagulation disorders risk factor nomogram predictive model |
| title | The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model |
| title_full | The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model |
| title_fullStr | The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model |
| title_full_unstemmed | The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model |
| title_short | The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model |
| title_sort | clinical features and risk factors of coagulopathy associated with cefoperazone sulbactam a nomogram prediction model |
| topic | cefoperazone/sulbactam coagulation disorders risk factor nomogram predictive model |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1505653/full |
| work_keys_str_mv | AT changjingxu theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT junlongzhu theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT kuntu theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT huitang theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT xinxinzhou theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT qiuyuli theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT kunchen theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT xupingyang theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT yilanhuang theclinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT changjingxu clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT junlongzhu clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT kuntu clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT huitang clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT xinxinzhou clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT qiuyuli clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT kunchen clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT xupingyang clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel AT yilanhuang clinicalfeaturesandriskfactorsofcoagulopathyassociatedwithcefoperazonesulbactamanomogrampredictionmodel |